Concepedia

John B. Mumm

JB

Statistics

Publications

22

Citations

3K

H-Index

19

Active since

1996

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

NewGen Therapeutics (United States)

Coherus BioSciences (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

National Institutes of Health

John B. Mumm is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, immunology, and life sciences.

ORCID

Publications per year

1996–2018

22

Publications

22

Quantitative analysis of hepatitis C virus-specific CD8 <sup>+</sup> T cells in peripheral blood and liver using peptide-MHC tetramers

Xiaosong He, Barbara Rehermann, F. Xavier López‐Labrador et al. · Proceedings of the National Academy of Sciences · 1999 · 415 citations · Full text

, , +17

IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance

John B. Mumm, Jan Emmerich, Xueqing Zhang et al. · Cancer Cell · 2011 · 414 citations · Full text

, , +10

IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without <i>De Novo</i> Infiltration from Secondary Lymphoid Organs

Jan Emmerich, John B. Mumm, Ivan H. Chan et al. · Cancer Research · 2012 · 267 citations

, , +17

The Protein Product of the Tumor Suppressor Gene, Melanoma Differentiation-Associated Gene 7, Exhibits Immunostimulatory Activity and Is Designated IL-24

Eva G. Caudell, John B. Mumm, Nancy Poı̀ndexter et al. · The Journal of Immunology · 2002 · 262 citations

, , +15

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients

Aung Naing, Jeffrey R. Infante, Kyriakos P. Papadopoulos et al. · Cancer Cell · 2018 · 251 citations · Full text

, , +17

1–5 of 22